Issuance of Stock Options as Equity Compensation
First written in FY2018-Q2. 16 of 18 entries say "Advanced", first in FY2018-Q3. Latest entry: 2026-09-25.
106 other companies' latest entry also says "Advanced".
- 2026-09-25AdvancedShare Issuance and Disposal
「当社は、本日開催の取締役会において、当社の取締役４名及び執行役員 14 名（以下「本対象者Ｃ」といいます。）に対し、業績条件付株式報酬制度の目的、各本対象者Ｃの職責の範囲その他諸般の事情を勘案し、金銭報酬債権合計 787,572,000 円と引き換えに、当社の普通株式 150,300 株を処分することを決議いたしました。」
業績条件付譲渡制限付株式150,300株の自己株式処分を決議し、従来の株式報酬制度を具体的な付与・処分として実行した。勤務条件型およびESG条件加重型も含め、役員・執行役員への株式報酬の実施を具体化している。 - FY2026AdvancedAnnual report
「Third Series of Stock Acquisition Rights (tax-qualified stock options). Eligible recipients and number: Employees, 78. Class, description and number of shares underlying the stock acquisition rights: 46,900 common shares. The stock acquisition rights granted may be exercised in full only if, in any fiscal year from the fiscal year ending June 2028 through the fiscal year ending June 2030, the Company’s net sales stated in the consolidated income statement in its annual securities report exceed ¥220,000 million.」
In addition to stock options in the form of equity compensation for officers, the Company granted 46,900 tax-qualified stock options to 78 employees, subject to net sales of ¥220,000 million. - FY2023-Q2AdvancedAnnual report
「27 October 2022 (Note) 5,738 12,118,250 20 2,883 20 2,756 (Note) Increase due to the issuance of new shares as restricted stock compensation.」
On 27 October 2022, 5,738 shares were issued as restricted stock compensation, increasing capital and capital surplus by ¥20 million each. - FY2023-Q1AdvancedAnnual report
「(Note) The total number of issued shares increased by 5,738, and capital and capital surplus each increased by ¥20 million through the issuance of new shares as restricted stock compensation, with 27 October 2022 as the payment date.」
The disclosure reports the issuance of 5,738 shares as restricted stock compensation and the planned and actual increase of ¥20 million each in capital and capital surplus. - FY2022-Q2AdvancedAnnual report
「28 October 2021 (Note) 1 2,640 12,073,082 10,084 2,759,569 10,084 2,632,420」
On 28 October 2021, 2,640 shares were issued as restricted stock compensation, and an increase of 12,220 shares through the exercise of stock acquisition rights was also reported for the cumulative second quarter. - FY2021AdvancedAnnual report
「The increase of 6,042,820 in the total number of issued common shares comprises an increase of 5,140 shares due to the exercise of stock acquisition rights, an increase of 2,459 shares due to the issuance of new shares as restricted stock compensation, and an increase of 6,035,221 shares due to the two-for-one split of common shares effective 1 March 2021.」
In FY2021, 5,140 shares were issued through the exercise of stock options with stock-based compensation, and 2,459 shares were issued as restricted stock compensation. - FY2021-Q2ReframedAnnual report
「Increase due to the issuance of new shares as restricted stock compensation. Issue price ¥9,890 Amount transferred to capital ¥4,945 Allottees 7 directors of the Company (excluding outside directors) and 6 executive officers of the Company」
In addition to the existing stock options with stock-based compensation, 2,459 shares were issued as restricted stock compensation for 7 directors and 6 executive officers. - FY2021-Q1AdvancedAnnual report
「1 July 2020–30 September 2020 (Note) 1 2,400 6,030,022 1,486 2,728,799 1,486 2,601,650 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the first quarter, 2,400 shares were issued through the exercise of stock acquisition rights, adding to the exercise results for stock options with stock-based compensation. - FY2020AdvancedAnnual report
「1 July 2019–30 June 2020 (Note) 1 7,240 6,027,622 7,696 2,727,313」
During the fiscal year, 7,240 shares were issued through the exercise of stock acquisition rights, adding to the operating and exercise results for stock options with stock-based compensation. - FY2020-Q3AdvancedAnnual report
「Change in total number of issued shares 2,700 Balance of total number of issued shares 6,024,922 (Note) 1. Increase due to the exercise of stock acquisition rights.」
Between January and March 2020, 2,700 shares were issued through the exercise of stock acquisition rights, and the exercise results for stock options with stock-based compensation were reported. - FY2020-Q2AdvancedAnnual report
「Number of stock acquisition rights (units) ※ 256 (Note) 1 Class, details and number of shares underlying the stock acquisition rights (shares) ※ Common shares 2,560 shares」
The issuance details for the fifth series of stock-based compensation stock options, comprising 256 stock acquisition rights covering 2,560 shares, were disclosed. - FY2019AdvancedAnnual report
「Fifth stock acquisition rights (Stock-based compensation stock options) Number of stock acquisition rights (units) 256 Class, details and number of shares underlying the stock acquisition rights Common shares 2,560 shares」
The issuance of the fifth series of stock-based compensation stock options, comprising 256 stock acquisition rights covering 2,560 shares, was approved on 25 September 2019. - FY2019-Q3AdvancedAnnual report
「Increase or decrease in total number of issued shares 1,200 6,020,382 743 2,719,616 743 2,592,467 (Note) Increase due to the exercise of stock acquisition rights.」
During the third quarter accounting period, the number of shares increased by 1,200 through the exercise of stock acquisition rights, and the exercise of stock-based compensation stock options was recorded. - FY2019-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. (Fourth stock acquisition rights for stock-based compensation, or stock-based compensation stock options, based on the resolution of the Board of Directors dated 26 September 2018) Number of stock acquisition rights (units) 240 Class, details and number of shares underlying the stock acquisition rights (shares) Common shares 2,400 shares」
As the fourth series of stock-based compensation stock options, 240 stock acquisition rights covering 2,400 shares were issued. During the second quarter accounting period, the number of shares also increased by 3,070 through the exercise of stock acquisition rights. - FY2019-Q1AdvancedAnnual report
「Increase or decrease in total number of issued shares 2,840 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the first quarter, the number of shares increased by 2,840 through the exercise of stock acquisition rights, and the exercise of stock-based compensation stock options was recorded. - FY2018AdvancedAnnual report
「Fourth stock acquisition rights (stock-based compensation stock options)") Number of stock acquisition rights (units) 240 Common shares 2,400 shares」
In addition to the vesting of the third stock-based compensation stock options, the issuance of the fourth series, comprising 240 stock acquisition rights covering 2,400 shares, based on the resolution dated 26 September 2018, was disclosed. - FY2018-Q3AdvancedAnnual report
「Increase or decrease in total number of issued shares 600 6,011,472 371 2,710,021 371 2,582,872 (Note) 1. Increase due to the exercise of stock acquisition rights.」
From January through March 2018, the number of shares increased by 600 through the exercise of stock acquisition rights, and the exercise of stock-based compensation stock options was recorded. - FY2018-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. (Third stock acquisition rights for stock-based compensation, or stock-based compensation stock options, based on the resolution of the Board of Directors dated 26 September 2017) Number of stock acquisition rights (units) 353 Number of shares underlying the stock acquisition rights (shares) 3,530 (10 shares per stock acquisition right)」
Based on the resolution of the Board of Directors dated 26 September 2017, 353 stock-based compensation stock options, covering 3,530 shares, were issued.